840 related articles for article (PubMed ID: 28578001)
1. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
3. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
4. Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.
Ishizawa M; Akagi D; Makishima M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986424
[TBL] [Abstract][Full Text] [Related]
5. Phorbol esters enhance 1α,25-dihydroxyvitamin D3-regulated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) gene expression through ERK-mediated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells.
Jiang Y; Fleet JC
Mol Cell Endocrinol; 2012 Sep; 361(1-2):31-9. PubMed ID: 22871965
[TBL] [Abstract][Full Text] [Related]
6. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
7. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
[TBL] [Abstract][Full Text] [Related]
8. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
Wang Y; Zhu J; DeLuca HF
Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
DeSmet ML; Fleet JC
J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
[TBL] [Abstract][Full Text] [Related]
10. The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes.
Zella LA; Meyer MB; Nerenz RD; Pike JW
Endocrinology; 2009 Aug; 150(8):3448-56. PubMed ID: 19423758
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
Yasuda K; Tohyama E; Takano M; Kittaka A; Ohta M; Ikushiro S; Sakaki T
J Steroid Biochem Mol Biol; 2018 Apr; 178():333-339. PubMed ID: 29425808
[TBL] [Abstract][Full Text] [Related]
12. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
13. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.
Matsunawa M; Amano Y; Endo K; Uno S; Sakaki T; Yamada S; Makishima M
Toxicol Sci; 2009 May; 109(1):50-8. PubMed ID: 19244278
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice.
Chow EC; Durk MR; Maeng HJ; Pang KS
Biopharm Drug Dispos; 2013 Oct; 34(7):402-16. PubMed ID: 23897575
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components.
Lee SM; Riley EM; Meyer MB; Benkusky NA; Plum LA; DeLuca HF; Pike JW
J Biol Chem; 2015 Jul; 290(29):18199-18215. PubMed ID: 26041780
[TBL] [Abstract][Full Text] [Related]
20. Strategies and limitations associated with in vitro characterization of vitamin D receptor activators.
Bukuroshi P; Saitoh H; Magomedova L; Cummins CL; Chow EC; Li AP; Pang KS
Biochem Pharmacol; 2018 Sep; 155():547-561. PubMed ID: 30028992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
